The most significant insider buy on today's list comes via two separate Form 4 filings by the president and the CEO of The Charles Schwab Corporation $SCHW.

They reported purchases for a combined amount of $2.2 million.

Here’s The Hot Corner, with data from July 19, 2024:

Director John W. Childs reported the acquisition of 28,400 shares in Biohaven Pharmaceutical Holding Company Ltd $BHVN.

BHVN came public in September 2022 and ripped higher with authority. However, price has retraced some gains since it peaked in March, successfully retesting a critical polarity level.

The line in the sand lies at 27.

If we're above this level, the risk is still to the upside.

Stay tuned. We'll be back on Tuesday with more insider activity.

And...

Investors are preparing themselves for the launch of a second wave of crypto ETFs. With Ethereum up over 25% in recent weeks, it's clear the market has positive expectations for these new products.

This is the weekly post that aggregates all the charts we put together throughout the week and organizes them all into one, easy to flip through deck.

From the Desk of Ian Culley @IanCulley

Risk assets are taking a hit.

The major equity indexes are seeing red. Crude oil is slipping below eighty bucks. And gold is failing at new all-time highs.

Perhaps the markets are navigating the summertime blues – a tune base and industrial metal investors have been humming for months.

Remember copper’s failed breakout in May:

Oof!

Dr. Copper is living up to the trading adage that from failed moves come fast moves in the opposite direction.

The futures continue to fall – down almost 8 percent this week. 

Meanwhile, track the 4.16 level for potential support:

That level coincides with a key retracement and former resistance area – a logical place for buyers to step in and defend price. 

On the other hand, momentum is drifting toward oversold conditions. If the 14-day RSI drops below 30, I imagine copper will reach...

From the Desk of Steve Strazza @Sstrazza

Breadth has expanded in a big way since last week, with more and more stocks finally joining in on the bull market as big-cap tech leaders take a breather.

At the sector and industry group level, our list of indexes that are in uptrends continues to grow.

Some notable new members on this list include regional banks, small-caps, and various speculative growth funds.

After years of basing in accumulation patterns, these groups are just now completing primary trend reversals.

What does this mean?

In its simplest form, it means there are more ponds we can fish in for long opportunities. There are more stocks -- and groups of stocks -- that are in uptrends.

It’s just more options for us.

One of the groups that has broken out with authority recently is the biotechs.

Regardless of what index you're looking at, the path of least resistance is now higher for this health care subsector.

We’ve identified some of the strongest biotech stocks with asymmetric risk/reward setups and clear levels to trade against.

We think these are the best vehicles to bet...

From the Desk of Steve Strazza @Sstrazza

Our International Hall of Famers list is composed of the 100 largest US-listed international stocks, or ADRs.

We've also sprinkled in some of the largest ADRs from countries that did not make the market cap cut. 

These stocks range from some well-known mega-cap multinationals such as Toyota Motor and Royal Dutch Shell to some large-cap global disruptors such as Sea Ltd and Shopify.

It's got all the big names and more–but only those that are based outside the US. You can find all the largest US stocks on our original Hall of Famers list.

The beauty of these scans is really in their simplicity.

We take the largest names each week and then apply technical filters in a way that the strongest stocks with the most momentum rise to the top.

Based on the market environment, we can also flip the scan on its head and filter for weakness.

Let's dive in and take a look at some of the most important stocks from around the world.

Here's this week's list:

...

From the Desk of Ian Culley @IanCulley

Risk assets are taking a hit.

The major equity indexes are seeing red. Crude oil is slipping below eighty bucks. And Gold is failing at new all-time highs.

Perhaps the markets are navigating the summertime blues – a tune base and industrial metal investors have been humming for months.

The most significant insider buy on today's list comes via a Form 4 filing by U.S. Bancorp $USB director Aleem Gillani.

Gillani reported the acquisition of 10,000 shares, equivalent to $449,900.

Here’s The Hot Corner, with data from July 18, 2024:

Boxer Capital LLC filed a 13G for uniQure N.V. $QURE revealing an initial stake of 5.10%.

After a prolonged decline since January 2022, US Bancorp stopped going down last year.

After price emerged from a rounding bottom formation, the stock transitioned into a sideways consolidation.

With a monster regional bank rally over the past two weeks, USB is right back at the upper bounds of its range.

We think it breaks out this time. 

Have a great weekend. We'll be back on Monday with more insider activity.

Here's this week's crypto roundup. It's an opportunity for us to take a step back, set aside the distractions, and delve into the key charts shaping the crypto complex.

In May of last year, David Yuan disclosed a $12,534,400 purchase of Toast Inc $TOST shares in an SEC Form-4 filing. 

Toast utilizes cloud-based software and hardware to deliver an all-in-one platform that covers point of sale, marketing, digital ordering, delivery, and more for the restaurant industry.

Yuan has been a member of Toast’s board since March 2019, playing a vital role in the company's governance and strategic direction. 

Such a sizable open-market purchase can only be interpreted as a demonstration of an insider's bullishness toward a stock.

The fact that Yuan is a seasoned growth investor with a long track record of success with other similar companies only makes the setup that much sweeter.

He currently runs Tidemark Capital, previously spent 15 years at Technology Crossover Ventures, and has been recognized by Forbes as one of the top 100 technology investors in the world.

Is it bearish when the largest component in the Dow Jones Industrial Average breaks out of a multi-year base to new all-time highs?

To be clear, we're talking about the world's most important stock market index here. And UnitedHealth represents over 8.5% of the entire Papa Dow.

Look at this chart. While people are telling you that the market is in a bubble, things are parabolic and this is unsustainable, the largest weighting of the most important stock market gauge hasn't even done anything for years.

Until now...

The most significant insider buy on today's list comes via a 13D filing by Gates Capital Management.

The investment firm revealed an increase in ownership from 9.45% to 9.60% in Vista Outdoor Inc $VSTO.

Here’s The Hot Corner, with data from July 17, 2024:

Perceptive Advisors LLC reported an increase in its ownership stake from 7.10% to 12.80% in Orchestra BioMed Holdings Inc $OBIO.

VST is resolving higher from a rounding bottom pattern.

As long as we’re above the 2023 highs, this is a valid trend reversal, and the path of least resistance points higher.

Stay tuned. We'll be back on Friday with more insider activity.

And please reach out with any questions. We love hearing from you!

From the Desk of Steve Strazza @Sstrazza

Welcome to The 2 to 100 Club.

As most of you know, we use various bottom-up tools and scans to complement our top-down approach.

It's really been working for us!

One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

Some of the best performers in recent decades – stocks like Priceline, Amazon, Netflix, Salesforce, and myriad others – would have been on this list at some point during their journey to becoming the market...

Counting is a lost art.

Humans love their short cuts.

Rather than taking the time to actually go one by one counting each of the stocks that are going up, down, or sideways, humans would rather skip that altogether in favor of their favorite Index or some kind of statistic.

 You don't need any sophisticated math skills in order to count how well or poorly the stock market is doing.

It's actually incredibly simple. 

Humans just don't want to do it.

And that's the arb.